PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder TreatmentsGlobe Newswire • 2 months agoTARRYTOWN, New York, March 13, 2024 (GLOBE NEWSWIRE) -- via IBN PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today...